Literature DB >> 9590397

Laboratory guidelines for monitoring of antimicrobial drugs. National Academy of Clinical Biochemistry.

C A Hammett-Stabler1, T Johns.   

Abstract

Few antimicrobial drugs meet the requirements for therapeutic drug monitoring. Those that are monitored include the aminoglycosides (gentamicin, tobramycin, and amikacin), chloramphenicol, and in some cases, vancomycin. For these drugs, there is evidence of a relationship between serum concentration, efficacy, and/or the incidence of adverse or toxic events. Monitoring begins with the appropriate timing of collection and continues through the analytical process to the integration of all data used to guide the clinician's next decision.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590397

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.

Authors:  Michael S Niederman; Jean Chastre; Kevin Corkery; James B Fink; Charles-Edouard Luyt; Miguel Sánchez García
Journal:  Intensive Care Med       Date:  2011-12-07       Impact factor: 17.440

2.  Recommendations for monitoring serum vancomycin concentrations.

Authors:  C W James; C Gurk-Turner
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-04

3.  Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.

Authors:  Gregory G Anderson; Thomas F Kenney; David L Macleod; Noreen R Henig; George A O'Toole
Journal:  Pathog Dis       Date:  2013-01-10       Impact factor: 3.166

4.  Achieving therapeutic vancomycin levels in pediatric patients.

Authors:  Jenny Hoang; Deonne Dersch-Mills; Lauren Bresee; Timothy Kraft; Otto G Vanderkooi
Journal:  Can J Hosp Pharm       Date:  2014-11

5.  Vancomycin administration: the impact of multidisciplinary interventions.

Authors:  R K Crowley; F Fitzpatrick; D Solanki; S FitzGerald; H Humphreys; E G Smyth
Journal:  J Clin Pathol       Date:  2007-02-09       Impact factor: 3.411

6.  Chloramphenicol causes mitochondrial stress, decreases ATP biosynthesis, induces matrix metalloproteinase-13 expression, and solid-tumor cell invasion.

Authors:  Ching-Hao Li; Yu-Wen Cheng; Po-Lin Liao; Ya-Ting Yang; Jaw-Jou Kang
Journal:  Toxicol Sci       Date:  2010-03-25       Impact factor: 4.849

7.  Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs.

Authors:  Manika Suryadevara; Kelly E Steidl; Luke A Probst; Jana Shaw
Journal:  J Pediatr Pharmacol Ther       Date:  2012-04

8.  Immediate Treatment of Burn Wounds with High Concentrations of Topical Antibiotics in an Alginate Hydrogel Using a Platform Wound Device.

Authors:  Kristo Nuutila; Josh Grolman; Lu Yang; Michael Broomhead; Stuart Lipsitz; Andrew Onderdonk; David Mooney; Elof Eriksson
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-12-18       Impact factor: 4.730

Review 9.  Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.

Authors:  Alicja Bartkowska-Śniatkowska; Katarzyna Jończyk-Potoczna; Marzena Zielińska; Jowita Rosada-Kurasińska
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

10.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

Authors:  David L MacLeod; Lynn M Barker; Jennifer L Sutherland; Suzanne C Moss; Jesse L Gurgel; Thomas F Kenney; Jane L Burns; William R Baker
Journal:  J Antimicrob Chemother       Date:  2009-08-13       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.